Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 8-15

  Terhune, Scott S ^c   Coleman, Kevin T ^b   Sekulovich, Rose ^c   Burke, Rae Lyn ^c   Spear, Patricia G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ARTICLE; CELL CULTURE; DISEASE SEVERITY; GENE SEQUENCE; GENETIC POLYMORPHISM; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS REPLICATION;

EID: 0031868159     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515590     Document Type: Article

References (25)

1. Hayward GS, Frenkel N, Roizman B. Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites. Proc Nat Acad Sci USA 1975;72:1768-72.
2. Roizman B, Tognon M. Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology. Curr Top Microbiol Immunol 1983;104:273-86.
3. Mannini-Palenzona A, Bartoletti AM, Foa-Tomasi L, et al. Study of herpes simplex virus type 1 populations obtained from recurrences and primary infections. J Med Virol 1985;15:17-28.
4. Epstein AL, Lyon M, Michal Y, Jacquemont B. In vitro divergence of HSV-1 populations propagated in different cell lines. Arch Virol 1990;111:133-40.
5. Spear PG. Entry of alphaherpesviruses into cells. Sem Virol 1993;4:167-80.
6. Herold BC, Gerber SI, Belval BJ, Siston AM, Shulman N. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J Virol 1996;70:3461-9.
7. Montgomery RI, Warner MS, Lum BJ, Spear PG. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996;87:427-36.
8. Whitbeck JC, Peng C, Lou H, et al. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol 1997;71:6083-93.
9. Dean HJ, Terhune S, Shieh MT, Susmarski N, Spear PG. Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell type-dependent alterations in infectivity. Virology 1994;199:67-80.
10. Munk K, Donner D. Cytopathischer effekt und plaque-morphologie verschiedener herpes-simplex-virus-Stämme. Arch Gesamte Virusforsch 1963;13:529-40.
11. Burke RL, Goldbeck C, Ng P, Stanberry L, Ott G, Van Nest G. The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. J Infect Dis 1994;170:1110-9.
12. Langenberg AG, Burke RL, Adair SF, et al. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann Intern Med 1995;122:889-98.
13. Zezulak KM, Spear PG. Characterization of a herpes simplex virus type 2 (HSV-2) 75,000-molecular-weight glycoprotein antigenically related to HSV-1 gC. J Virol 1983;47:553-62.
14. Stuve L, Brown-Shimer S, Pachl C, Najarian R, Dina D, Burke RL. Structure and expression of the herpes virus type 2 glycoprotein gB gene. J Virol 1987;61:326-35.
15. Swain MA, Peet RW, Galloway DA. Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J Virol 1985;53:561-9.
16. Watson RJ. DNA sequence of the herpes simplex virus type 2 glycoprotein D gene. Gene 1983;26:307-12.
17. Mertz GJ, Ashey R, Burke RL, et al. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis 1990;161:653-60.
18. Rojas JM, Sanchez-Palomino S, Santana M, Lopez-Galindez C, Tabares E. Genetic analysis of herpes simplex virus type 1 isolates from recurrent lesions and clinical reinfections. J Infect Dis 1995;172:1602-5.
19. Roizman B, Buchman T. The molecular epidemiology of herpes simplex viruses. Hosp Pract 1979;January:95-104.
20. Navarro D, Paz P, Pereira L. Domains of herpes simplex vims 1 glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology 1992;186:99-112.
21. Goade DE, Bell R, Yamada T, Mertz GJ, Jenison S. Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies. J Virol 1996;70:2950-6.
22. Pereira L. Function of glycoprotein B homologues of the family herpesviridae. Infect Agents Dis 1994;3:9-28.
23. Basgoz N, Qadri I, Navarro D, et al. The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. J Gen Virol 1992;73:983-8.
24. Chou S. Comparative analysis of sequence variation in gp116 and go55 components of glycoprotein B of human cytomegalovirus. Virology 1992;188:388-90.
25. Lehner R, Stamminger T, Mach M. Comparative sequence analysis of human cytomegalovirus strains. J Clin Microbiol 1991;29:2494-502.